TABLE 1.
Baseline Characteristics
| Glargine Group (n = 1,659) | Detemir Group (n = 1,659) | P | |
|---|---|---|---|
| Age, years* | 64 ± 14.7 | 63 ± 14.3 | 0.019 |
| Male sex, n (%) | 774 (46.7) | 779 (47.0) | 0.862 |
| Race, n (%) African American Asian Caucasian Other |
870 (52.4) 4 (0.2) 649 (39.1) 136 (8.2) |
852 (51.4) 9 (0.5) 691 (41.7) 107 (6.4) |
0.076 |
| BMI, kg/m2* | 31.2 ± 11.2 | 31.7 ± 12.2 | 0.214 |
| Baseline SCr, mg/dL* | 1.4 ± 1.4 | 1.5 ± 1.7 | 0.081 |
| A1C, %* | 8.5 ± 2.3 | 8.6 ± 2.2 | 0.326 |
| Initial blood glucose, mg/dL* | 213.0 ± 93.2 | 211.1 ± 91.7 | 0.555 |
| Bacteremia, n (%) | 10 (0.6) | 51 (3.1) | <0.001 |
| Insulin scale, n (%) High intensity Medium intensity Low intensity ICU Custom |
292 (17.6) 747 (45.0) 418 (25.2) 10 (0.6) 221 (13.3) |
357 (21.5) 1101 (66.4) 529 (31.9) 19 (1.1) 121 (7.3) |
0.004 <0.001 <0.001 0.093 <0.001 |
| Beta-blocker, n (%) | 968 (58.3) | 1122 (67.6) | <0.001 |
| Steroid, n (%) | 263 (15.9) | 324 (19.5) | 0.006 |
*
Mean ± SD.